BioNano Genomics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; BioNano Genomics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 9.32M	$ 8.66M	$ 7.42M	$ 8.21M	$ 7.22M
Gross Profit	$ 2.75M	$ 2.31M	$ 2.07M	$ 1.80M	$ 1.81M
EBIT	$ -112.46M	$ -38.80M	$ -37.02M	$ -37.57M	$ -31.71M
EBITDA	$ -108.86M	$ -35.60M	$ -33.86M	$ -34.75M	$ -29.28M
Net Income Common Stockholders	$ -112.57M	$ -38.91M	$ -37.12M	$ -38.68M	$ -31.81M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 63.60M	$ 77.10M	$ 95.80M	$ 113.20M	$ 180.19M
Total Assets	$ 181.90M	$ 271.42M	$ 292.15M	$ 307.50M	$ 323.70M
Total Debt	$ 10.14M	$ 10.66M	$ 11.17M	$ 11.67M	$ 10.39M
Net Debt	$ -53.46M	$ -66.44M	$ -84.63M	$ -101.53M	$ -169.80M
Total Liabilities	$ 62.91M	$ 56.63M	$ 60.66M	$ 58.10M	$ 41.96M
Stockholders Equity	$ 119.00M	$ 214.71M	$ 231.49M	$ 249.40M	$ 281.74M
Cash Flow	-
Free Cash Flow	$ -24.04M	$ -35.93M	$ -32.40M	$ -34.73M	$ -29.76M
Operating Cash Flow	$ -24.07M	$ -35.90M	$ -32.40M	$ -34.52M	$ -29.47M
Investing Cash Flow	$ 31.21M	$ 28.79M	$ 16.53M	$ 11.61M	$ 7.95M
Financing Cash Flow	$ 12.59M	$ 17.88M	$ 14.86M	$ 146.00K	$ 22.65M

Currency in USD

BioNano Genomics Earnings and Revenue History

Income Statement >

BioNano Genomics Debt to Assets

Balance Sheet >

BioNano Genomics Cash Flow

Cash Flow >

BioNano Genomics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing